US indicts two Indians for smuggling counterfeit Ozempic despite FDA warnings
The story in brief
Two Indian nationals, Swapnadip Roy and Vicky Ramancha, were indicted for smuggling counterfeit Ozempic, which continued despite FDA seizures in December 2023. Roy pleaded not guilty after extradition, while Ramancha remains at large. The fake drug, sold between July 2023 and April 2024, mimicked authentic packaging.